open access
Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers
Affiliations- Department of Haematology, Institute of Haematology and Transfusion Medicine, Warszawa, Poland
- Department of Physiotherapy and Emergency Medicine, Pomeranian University, Słupsk, Poland
- Department of Haematology, Collegium Medicum of Jagiellonian University, Kraków, Poland
- Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, Poland
- Department of Haematology, Clinical Voivodeship Hospital no. 1, Rzeszów, Poland
- Clinical Ward of Haematology, University Hospital, Kraków, Poland
- Department of Haematology and Steam Cell Transplantation, University of Medical Sciences, Poznań, Poland
- Department of Haematology, Blood Neoplasm and Bone Marrows Transplantation, Medical University, Wrocław, Poland
open access
Abstract
Abstract
About this articleTitle
Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers
Journal
Issue
Article type
Review paper
Pages
167-179
Published online
2019-06-26
Page views
784
Article views/downloads
978
DOI
10.5603/OCP.2019.0021
Bibliographic record
Oncol Clin Pract 2019;15(3):167-179.
Authors
Krzysztof Warzocha
Wojciech Homenda
Andrzej Pluta
Tomasz Sacha
Maria Cioch
Marek Dudziński
Dorota Krochmalczyk
Joanna Góra-Tybor
Ilona Seferyńska
Monika Joks
Marta Sobas